semaglutide pregnancy discontinue 2 months before planned pregnancy label exposure in early and outcomes: A case report and review of literature If you're on a GLP-1

7.3 Screening, monitoring, and stepped-care management To avoid over-pathologizing, a stepped-care approach is recommended

Authorship Authored by Shereen Amin Pharmacist Independent Prescriber & Medical Writer GPhC: 2073003 Shereen is a Pharmacist Independent Prescriber and medical writer with over ten years' experience across NHS primary care, digital health and specialist services

Wegovy is typically administered as a weekly injection , and its essential to pay attention to side effects including nausea, dizziness, or gastrointestinal discomfort

Achieve lasting wellness with one-on-one guidance and real, visible results

Emerging evidence suggests GLP-1 receptor agonists are associated with increased gallstone risk, with clinical trials showing gallbladder disorders in approximately 2.6% of patients on semaglutide versus 1.2% on placebo

doi:10.1093/ckj/sfae380